These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21107702)

  • 41. Direct interaction between p53 and Tid1 proteins affects p53 mitochondrial localization and apoptosis.
    Trinh DLN; Elwi AN; Kim SW
    Oncotarget; 2010 Oct; 1(6):396-404. PubMed ID: 21311096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition.
    Aggarwal M; Saxena R; Asif N; Sinclair E; Tan J; Cruz I; Berry D; Kallakury B; Pham Q; Wang TTY; Chung FL
    J Exp Clin Cancer Res; 2019 Jul; 38(1):307. PubMed ID: 31307507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TPP-related mitochondrial targeting copper (II) complex induces p53-dependent apoptosis in hepatoma cells through ROS-mediated activation of Drp1.
    Shao J; Li M; Guo Z; Jin C; Zhang F; Ou C; Xie Y; Tan S; Wang Z; Zheng S; Wang X
    Cell Commun Signal; 2019 Nov; 17(1):149. PubMed ID: 31744518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reactivation of mutant p53 by capsaicin, the major constituent of peppers.
    Garufi A; Pistritto G; Cirone M; D'Orazi G
    J Exp Clin Cancer Res; 2016 Sep; 35(1):136. PubMed ID: 27599722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stress-induced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species.
    Karawajew L; Rhein P; Czerwony G; Ludwig WD
    Blood; 2005 Jun; 105(12):4767-75. PubMed ID: 15705792
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination of doxorubicin and sulforaphane for reversing doxorubicin-resistant phenotype in mouse fibroblasts with p53Ser220 mutation.
    Fimognari C; Lenzi M; Sciuscio D; Cantelli-Forti G; Hrelia P
    Ann N Y Acad Sci; 2007 Jan; 1095():62-9. PubMed ID: 17404018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The combination of 5-fluorouracil plus p53 pathway restoration is associated with depletion of p53-deficient or mutant p53-expressing putative colon cancer stem cells.
    Huang C; Zhang XM; Tavaluc RT; Hart LS; Dicker DT; Wang W; El-Deiry WS
    Cancer Biol Ther; 2009 Nov; 8(22):2186-93. PubMed ID: 19923910
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A high-content chemical screen identifies ellipticine as a modulator of p53 nuclear localization.
    Xu GW; Mawji IA; Macrae CJ; Koch CA; Datti A; Wrana JL; Dennis JW; Schimmer AD
    Apoptosis; 2008 Mar; 13(3):413-22. PubMed ID: 18181020
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
    Buondonno I; Gazzano E; Jean SR; Audrito V; Kopecka J; Fanelli M; Salaroglio IC; Costamagna C; Roato I; Mungo E; Hattinger CM; Deaglio S; Kelley SO; Serra M; Riganti C
    Mol Cancer Ther; 2016 Nov; 15(11):2640-2652. PubMed ID: 27466354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. siRNA-mediated type 1 insulin-like growth factor receptor silencing induces chemosensitization of a human liver cancer cell line with mutant P53.
    Niu J; Xu Z; Li XN; Han Z
    Cell Biol Int; 2007 Feb; 31(2):156-64. PubMed ID: 17097318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Balance of NF-kappaB and p38 MAPK is a determinant of radiosensitivity of the AML-2 and its doxorubicin-resistant cell lines.
    Choi CH; Xu H; Bark H; Lee TB; Yun J; Kang SI; Oh YK
    Leuk Res; 2007 Sep; 31(9):1267-76. PubMed ID: 17218010
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Wild type p53 sensitizes soft tissue sarcoma cells to doxorubicin by down-regulating multidrug resistance-1 expression.
    Zhan M; Yu D; Lang A; Li L; Pollock RE
    Cancer; 2001 Sep; 92(6):1556-66. PubMed ID: 11745235
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blocking mitochondrial permeability transition prevents p53 mitochondrial translocation during skin tumor promotion.
    Liu J; St Clair DK; Gu X; Zhao Y
    FEBS Lett; 2008 Apr; 582(9):1319-24. PubMed ID: 18358838
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involvement of p53 in specific anti-neuroectodermal tumor activity of aloe-emodin.
    Pecere T; Sarinella F; Salata C; Gatto B; Bet A; Dalla Vecchia F; Diaspro A; Carli M; Palumbo M; Palù G
    Int J Cancer; 2003 Oct; 106(6):836-47. PubMed ID: 12918060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Irradiation-induced translocation of p53 to mitochondria in the absence of apoptosis.
    Essmann F; Pohlmann S; Gillissen B; Daniel PT; Schulze-Osthoff K; Jänicke RU
    J Biol Chem; 2005 Nov; 280(44):37169-77. PubMed ID: 16148012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mitochondrial-mediated apoptosis in lymphoma cells by the diterpenoid lactone andrographolide, the active component of Andrographis paniculata.
    Yang S; Evens AM; Prachand S; Singh AT; Bhalla S; David K; Gordon LI
    Clin Cancer Res; 2010 Oct; 16(19):4755-68. PubMed ID: 20798229
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The mechanism of ellipticine-induced apoptosis and cell cycle arrest in human breast MCF-7 cancer cells.
    Kuo PL; Hsu YL; Chang CH; Lin CC
    Cancer Lett; 2005 Jun; 223(2):293-301. PubMed ID: 15896464
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Curcumin induces p53-independent necrosis in H1299 cells via a mitochondria-associated pathway.
    Li F; Chen X; Xu B; Zhou H
    Mol Med Rep; 2015 Nov; 12(5):7806-14. PubMed ID: 26460892
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serine 392 phosphorylation modulates p53 mitochondrial translocation and transcription-independent apoptosis.
    Castrogiovanni C; Waterschoot B; De Backer O; Dumont P
    Cell Death Differ; 2018 Jan; 25(1):190-203. PubMed ID: 28937686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
    Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
    Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.